References
- Derk, CT. and Jimenez, SA. (2003) "Systemic sclerosis: current views of its pathogenesis", Autoimmun. Rev. 2, 181–191.
- Zhou, X., Tan, F.K., Wang, N., Xiong, M., Maghidman, S., Reveille, J.D., Milewicz, D.M., Chakraborty, R. and Arnett, F.C. (2003) "Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence", Arthritis Rheum. 48, 2585–2592.
- Aryal, BK., Khuder, S.A. and Schaub, E.A. (2001) "Meta-analysis of systemic sclerosis and exposure to solvents", Am. J. Ind. Med. 40, 271–274.
- Nelson, J.L. (2003) "Microchimerism in human health and disease", Autoimmunity 36, 5–9.
- Hamamdzic, D., Kasman, L.M. and LeRoy, E.C. (2002) `The role of infectious agents in the pathogenesis of systemic sclerosis", Curr. Opin. Rheumatol. 14, 694–698.
- Oldstone, M.B. (1998) "Molecular mimicry and immune-mediated diseases", FASEB J. 12, 1255–1265.
- Pandey, J.P. and LeRoy, E.C. (1998) "Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially sclero-derma), allograft rejection, and coronary restenosis", Arthritis Rheum. 41, 10–15.
- Ferri, C., Cazzato, M., Giuggioli, D., Sebastiani, M. and Magro, C. (2002) "Systemic sclerosis following human cytomegalovirus infection", Ann. Rheum. Dis. 61, 937–938.
- Neidhart, M., Kuchen, S., Distler, 0., Bruhlmann, P., Michel, BA., Gay, RE. and Gay, S. (1999) "Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis", Arthritis Rheum. 42, 389–392.
- Muryoi, T., Kasturi, K.N., Kafina, M.J., Cram, D.S., Harrison, L.C., Sasaki, T. and Bona, C.A. (1992) "Anti-topoisomerase monoclonal antibodies from scleroderma patients and tight skin mouse interact with similar epitopes", J. Exp. Med. 175, 1103–1109.
- Lunardi, C., Bason, C., Navone, R., Millo, E., Damonte, G., Corrocher, R. and Puccetti, A. (2000) "Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells", Nat. Med. 6, 1183–1186.
- Sgonc, R., Gruschwitz, M.S., Dietrich, H., Recheis, H., Gershwin, ME. and Wick, G. (1996) "Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma", J. Clin. Investig. 98, 785–792.
- Arnett, F.C. (1995) "HLA and autoimmunity in scleroderma (systemic sclerosis)", Int. Rev. Immunol. 12, 107–128.
- Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) "Preliminary criteria for the classifica-tion of systemic sclerosis (scleroderma)", Arthritis Rheum. 23, 581–590.
- Kuwana, M., Pandey, IP., Silver, R.M., Kawakami, Y. and Kaburald, J. (2003) "F1LA class II alleles in systemic sclerosis patients with anti-RNA polymerase 1/11I antibody: associations with subunit reactivities", J. Rheumatol. 30, 2392–2397.
- Petersen, J.L., Morris, C.R. and Solheim, J.C. (2003) "Virus evasion of MHC class I molecule presentation", J. Immunol. 171, 4473–4478.
- Li, N., Aoki, V., Hans-Filho, G., Rivitti, E.A. and Diaz, L.A. (2003) "The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem)", J. Exp. Med. 197, 1501–1510.